jak

Review: Approving, Using JAK Inhibitors for Better Alopecia Areata Outcomes

AJMC.com Managed Markets Network - 14 Nov 2024
Review: Approving, Using JAK Inhibitors for Better Alopecia Areata Outcomes ...

Are Janus kinase inhibitors a JAKpot for allergy relief?

DVM 360 - 14 Nov 2024
Are Janus kinase inhibitors a JAKpot for allergy relief? ...

JAK/STAT signaling maintains an intermediate cell population during prostate basal cell fate determination

Nature.com - 13 Nov 2024
JAK/STAT signaling maintains an intermediate cell population during prostate basal cell fate determination ...

JAK Inhibition in the Treatment of Alopecia Areata

MD Magazine - 11 Nov 2024
JAK Inhibition in the Treatment of Alopecia Areata ...

Dr DeAngelo on the Integration of JAK Inhibitors in Myelofibrosis Management

OncLive - 11 Nov 2024
Dr DeAngelo on the Integration of JAK Inhibitors in Myelofibrosis Management ...

20 Years Ago, Naughty Dog Left Jak & Daxter On a High Note With Jak 3

GameRant - 09 Nov 2024
20 Years Ago, Naughty Dog Left Jak & Daxter On a High Note With Jak 3 ...

What to Know About JAKne — JAK Inhibitor-Associated Acne

Medscape - 22 Aug 2024
What to Know About JAKne — JAK Inhibitor-Associated Acne ...

Recent popularity of JAK inhibitors in atopic dermatitis

Clinical Trials Arena - 05 Nov 2024
Recent popularity of JAK inhibitors in atopic dermatitis ...

JAK Inhibitors Improve Immune Checkpoint Inhibitors

NCI Cancer Bulletin - 08 Aug 2024
JAK Inhibitors Improve Immune Checkpoint Inhibitors ...

JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens

Frontiers - 24 Jun 2024
JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens ...

Fierce Pharma Asia—AstraZeneca's China fallout; Pfizer's $1B plan in China; Incyte-Sun JAK dispute

FiercePharma - 08 Nov 2024
Fierce Pharma Asia—AstraZeneca's China fallout; Pfizer's $1B plan in China; Incyte-Sun JAK dispute ...

Jak Crawford to drive AMR24 in Abu Dhabi Young Driver Test

Aston Martin F1 Team - 17 Oct 2024
Jak Crawford to drive AMR24 in Abu Dhabi Young Driver Test ...

Recludix Pharma to Present Data Demonstrating its Oral STAT3 Inhibitor has Differentiated Efficacy and Safety as Compared to JAK/TYK2 Inhibition in In Vivo Models of Inflammatory Arthritis

The Manila Times - 14 Nov 2024
Recludix Pharma to Present Data Demonstrating its Oral STAT3 Inhibitor has Differentiated Efficacy and Safety as Compared to JAK/TYK2 Inhibition in In Vivo Models of Inflammatory Arthritis ...

Review: Approving, Using JAK Inhibitors for Better Alopecia Areata Outcomes

Are Janus kinase inhibitors a JAKpot for allergy relief?

JAK/STAT signaling maintains an intermediate cell population during prostate basal cell fate determination

JAK Inhibition in the Treatment of Alopecia Areata

Dr DeAngelo on the Integration of JAK Inhibitors in Myelofibrosis Management

20 Years Ago, Naughty Dog Left Jak & Daxter On a High Note With Jak 3

What to Know About JAKne — JAK Inhibitor-Associated Acne

Recent popularity of JAK inhibitors in atopic dermatitis

JAK Inhibitors Improve Immune Checkpoint Inhibitors

JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens

Fierce Pharma Asia—AstraZeneca's China fallout; Pfizer's $1B plan in China; Incyte-Sun JAK dispute

Jak Crawford to drive AMR24 in Abu Dhabi Young Driver Test

Recludix Pharma to Present Data Demonstrating its Oral STAT3 Inhibitor has Differentiated Efficacy and Safety as Compared to JAK/TYK2 Inhibition in In Vivo Models of Inflammatory Arthritis

JAK inhibition combats adverse skin reaction

Review of FDA Approved JAK Inhibitors for Alopecia Areata

Study Reports Safety Data in Children on JAK Inhibitors

FDA Approves JAK Inhibitor Deuruxolitinib for Alopecia Areata

The JAK-STAT pathway: from structural biology to cytokine engineering | Signal Transduction and Targeted Therapy

JAK inhibitor selectivity: new opportunities, better drugs?

What's New

Get in touch